82: Regenerating Muscles: The Future of Autologous Cell-based Therapy with Deana Mohr - Part 2
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation - Un pódcast de David Brühlmann - CMC Development Leader, Biotech C-level Advisor, Business Strategist
Send us a textDive into the cutting-edge world of autologous cell-based therapy with Deana Mohr, CEO and co-founder of MUVON Therapeutics, spin-off from the University of Zurich. In this eye-opening episode, discover how MUVON Therapeutics’ innovative approach to muscle regeneration is revolutionizing treatments for stress urinary incontinence and beyond.Learn how her team is tackling the challenges of bringing personalized medicine to market at scale, from navigating complex regulations to a...
